{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T12:14:35Z","timestamp":1742645675389},"posted":{"date-parts":[[2023,5,11]]},"group-title":"In Review","reference-count":33,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,4,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p><jats:bold>Background<\/jats:bold> Repurposing dantrolene as a potential disease-modifying treatment for Alzheimer\u2019s disease has been shown to be effective in amyloid transgenic mouse models but has not been examined in a model of tauopathy.<jats:bold>Objective<\/jats:bold> The effects of a nanoparticle intranasal formulation, the Eagle Research Formulation of Ryanodex (ERFR), in young adult and aged wild type and PS19 tau transgenic mice was investigated.<jats:bold>Methods<\/jats:bold> The bioavailability of intranasal ERFR was measured in 2 months and 9\u201312 month old C57BL\/6J male mice. Mice received a single intranasal dose of ERFR and, after 20 min, blood and brain samples were collected. Dantrolene concentrations in the plasma and brain were analyzed by High Performance Liquid Chromatography. Animal behavior was examined in PS19 tau transgenic mice, with\/without acrolein treatment to exacerbate cognitive deficits. Behavioral tests included cognition (cued and contextual fear conditioning, y-maze), motor function (rotarod), and olfaction (buried food test).<jats:bold>Results<\/jats:bold> Dantrolene concentration in the blood and brain decreased with age, though the decrease was greater in the blood resulting in a higher brain to blood concentration ratio. The behavioral assays showed no significant changes in cognition, olfaction or motor function in the PS19 mice compared to controls after chronic ERFR treatment even with acrolein treatment.<jats:bold>Conclusion<\/jats:bold> Our studies suggest that while we did not find PS19 mice to be a reliable Alzheimer animal model to test the therapeutic efficacy of dantrolene, the results suggest a potential for ERFR to be an effective chronic therapy for Alzheimer\u2019s disease and that further studies are indicated.<\/jats:p>","DOI":"10.21203\/rs.3.rs-2802620\/v1","type":"posted-content","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T14:13:01Z","timestamp":1683814381000},"source":"Crossref","is-referenced-by-count":2,"title":["Effects of intranasal dantrolene nanoparticles on brain concentration and behavior in PS19 tau transgenic mice"],"prefix":"10.21203","author":[{"given":"Robert","family":"Vera","sequence":"first","affiliation":[{"name":"University of Pennsylvania, Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Hong","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bailin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Peking University People's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Liang","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryellen F","family":"Eckenhoff","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halle J","family":"Kincaid","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veron","family":"Browne","sequence":"additional","affiliation":[{"name":"Eagle Pharmaceuticals, Inc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinolia","family":"Chellaraj","sequence":"additional","affiliation":[{"name":"Eagle Pharmaceuticals, Inc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Gisewhite","sequence":"additional","affiliation":[{"name":"Eagle Pharmaceuticals, Inc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Eagle Pharmaceuticals, Inc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Ranjan","sequence":"additional","affiliation":[{"name":"Eagle Pharmaceuticals, Inc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaozhong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Eagle Pharmaceuticals, Inc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huafeng","family":"Wei","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Perelman School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer's disease facts and figures","volume":"17","year":"2021","unstructured":"2021 Alzheimer's disease facts and figures. Alzheimers Dement, 2021. 17(3): p.\u00a0327\u2013406.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene - A review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause T","year":"2004","unstructured":"Krause, T., et al., Dantrolene - A review of its pharmacology, therapeutic use and new developments. Anaesthesia, 2004. 59(4): p.\u00a0364\u2013373.","journal-title":"Anaesthesia"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2012.04.008","article-title":"Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice","volume":"516","author":"Peng J","year":"2012","unstructured":"Peng, J., et al., Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice. Neurosci Lett, 2012. 516(2): p.\u00a0274\u20139.","journal-title":"Neurosci Lett"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000374","article-title":"Calcium Dysregulation in Alzheimer's Disease: A Target for New Drug Development","volume":"7","author":"Wang Y","year":"2017","unstructured":"Wang, Y., Y. Shi, and H. Wei, Calcium Dysregulation in Alzheimer's Disease: A Target for New Drug Development. J Alzheimers Dis Parkinsonism, 2017. 7(5).","journal-title":"J Alzheimers Dis Parkinsonism"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2174\/1871527317666180619162649","article-title":"Dantrolene: From Malignant Hyperthermia to Alzheimer's Disease","volume":"18","author":"Shi Y","year":"2019","unstructured":"Shi, Y., Y. Wang, and H. Wei, Dantrolene: From Malignant Hyperthermia to Alzheimer's Disease. CNS Neurol Disord Drug Targets, 2019. 18(9): p.\u00a0668\u2013676.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3233\/JAD-200227","article-title":"Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice","volume":"76","author":"Shi Y","year":"2020","unstructured":"Shi, Y., et al., Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice. J Alzheimers Dis, 2020. 76(4): p.\u00a01375\u20131389.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/ALN.0000000000003224","article-title":"Dantrolene Ameliorates Impaired Neurogenesis and Synaptogenesis in Induced Pluripotent Stem Cell Lines Derived from Patients with Alzheimer's Disease","volume":"132","author":"Wang Y","year":"2020","unstructured":"Wang, Y., et al., Dantrolene Ameliorates Impaired Neurogenesis and Synaptogenesis in Induced Pluripotent Stem Cell Lines Derived from Patients with Alzheimer's Disease. Anesthesiology, 2020. 132(5): p.\u00a01062\u20131079.","journal-title":"Anesthesiology"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"e52056","DOI":"10.1371\/journal.pone.0052056","article-title":"Stabilizing ER Ca(2+) Channel Function as an Early Preventative Strategy for Alzheimer's Disease","volume":"7","author":"Chakroborty S","year":"2012","unstructured":"Chakroborty, S., et al., Stabilizing ER Ca(2+) Channel Function as an Early Preventative Strategy for Alzheimer's Disease. PLoS One., 2012. 7(12): p.\u00a0e52056.","journal-title":"PLoS One."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","article-title":"Dantrolene is neuroprotective in Huntington's disease transgenic mouse model","volume":"6","author":"Chen X","year":"2011","unstructured":"Chen, X., et al., Dantrolene is neuroprotective in Huntington's disease transgenic mouse model. Mol Neurodegener, 2011. 6: p.\u00a081.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1046\/j.1471-4159.1996.67062390.x","article-title":"Dantrolene is cytoprotective in two models of neuronal cell death","volume":"67","author":"Wei HF","year":"1996","unstructured":"Wei, H.F. and D.C. Perry, Dantrolene is cytoprotective in two models of neuronal cell death. Journal of Neurochemistry, 1996. 67(6): p.\u00a02390\u20132398.","journal-title":"Journal of Neurochemistry"},{"issue":"1\u20132","key":"ref11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2005.04.058","article-title":"The protective effect of dantrolene on ischemic neuronal cell death is associated with reduced expression of endoplasmic reticulum stress markers","volume":"1048","author":"Li F","year":"2005","unstructured":"Li, F., et al., The protective effect of dantrolene on ischemic neuronal cell death is associated with reduced expression of endoplasmic reticulum stress markers. Brain Research, 2005. 1048(1\u20132): p.\u00a059\u201368.","journal-title":"Brain Research"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0300-9572(00)00369-5","article-title":"Dantrolene ameliorates delayed cell death and concomitant DNA fragmentation in the rat hippocampal CA1 neurons subjected to mild ischemia","volume":"50","author":"Yano T","year":"2001","unstructured":"Yano, T., et al., Dantrolene ameliorates delayed cell death and concomitant DNA fragmentation in the rat hippocampal CA1 neurons subjected to mild ischemia. Resuscitation, 2001. 50(1): p.\u00a0117\u201325.","journal-title":"Resuscitation"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s00586-009-1033-6","article-title":"Dantrolene can reduce secondary damage after spinal cord injury","volume":"18","author":"Aslan A","year":"2009","unstructured":"Aslan, A., et al., Dantrolene can reduce secondary damage after spinal cord injury. European Spine Journal, 2009. 18(10): p.\u00a01442\u20131451.","journal-title":"European Spine Journal"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.spinee.2017.10.067","article-title":"Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats","volume":"18","author":"Martins BC","year":"2018","unstructured":"Martins, B.C., et al., Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats. Spine J, 2018. 18(3): p.\u00a0532\u2013539.","journal-title":"Spine J"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0028-3908(99)00059-3","article-title":"Neuroprotective effects of early vs. late administration of dantrolene in experimental status epilepticus","volume":"38","author":"Niebauer M","year":"1999","unstructured":"Niebauer, M. and M. Gruenthal, Neuroprotective effects of early vs. late administration of dantrolene in experimental status epilepticus. Neuropharmacology, 1999. 38(9): p.\u00a01343\u20138.","journal-title":"Neuropharmacology"},{"issue":"9","key":"ref16","first-page":"555","article-title":"Dantrolene: A Selective Ryanodine Receptor Antagonist, Protects Against Pentylenetetrazole-Induced Seizure in Mice","volume":"54","author":"Keshavarz M","year":"2016","unstructured":"Keshavarz, M., M. Fotouhi, and A. Rasti, Dantrolene: A Selective Ryanodine Receptor Antagonist, Protects Against Pentylenetetrazole-Induced Seizure in Mice. Acta Med Iran, 2016. 54(9): p.\u00a0555\u2013561.","journal-title":"Acta Med Iran"},{"key":"ref17","author":"Magi S","year":"2016","unstructured":"Magi, S., et al., Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease. Biomed Res Int, 2016. 2016: p.\u00a06701324."},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"e22196","DOI":"10.1002\/syn.22196","article-title":"Mitochondria-associated endoplasmic reticulum membranes: At the crossroad between familiar and sporadic Alzheimer's disease","volume":"75","author":"Wang K","year":"2021","unstructured":"Wang, K. and W. Zhang, Mitochondria-associated endoplasmic reticulum membranes: At the crossroad between familiar and sporadic Alzheimer's disease. Synapse, 2021. 75(6): p.\u00a0e22196.","journal-title":"Synapse"},{"issue":"11 Pt B","key":"ref19","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bbamcr.2018.07.018","article-title":"Calcium signaling in Alzheimer's disease & therapies","volume":"1865","author":"Tong BC","year":"2018","unstructured":"Tong, B.C., et al., Calcium signaling in Alzheimer's disease & therapies. Biochim Biophys Acta Mol Cell Res, 2018. 1865(11 Pt B): p.\u00a01745\u20131760.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3233\/JAD-200770","article-title":"Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis","volume":"78","author":"Li X","year":"2020","unstructured":"Li, X., et al., Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis. J Alzheimers Dis, 2020. 78(4): p.\u00a01315\u20131338.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00001756-199612200-00074","article-title":"Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide","volume":"8","author":"Guo Q","year":"1996","unstructured":"Guo, Q., et al., Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport, 1996. 8(1): p.\u00a0379\u201383.","journal-title":"Neuroreport"},{"issue":"34","key":"ref22","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1523\/JNEUROSCI.0875-12.2012","article-title":"Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease","volume":"32","author":"Oules B","year":"2012","unstructured":"Oules, B., et al., Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease. J Neurosci, 2012. 32(34): p.\u00a011820\u201334.","journal-title":"J Neurosci"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"e0229156","DOI":"10.1371\/journal.pone.0229156","article-title":"Intranasal administration of dantrolene increased brain concentration and duration","volume":"15","author":"Wang J","year":"2020","unstructured":"Wang, J., et al., Intranasal administration of dantrolene increased brain concentration and duration. PLoS One, 2020. 15(3): p.\u00a0e0229156.","journal-title":"PLoS One"},{"issue":"25","key":"ref24","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","article-title":"Role of presenilins in neuronal calcium homeostasis","volume":"30","author":"Zhang H","year":"2010","unstructured":"Zhang, H., et al., Role of presenilins in neuronal calcium homeostasis. J Neurosci, 2010. 30(25): p.\u00a08566\u201380.","journal-title":"J Neurosci"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00401-015-1458-4","article-title":"Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections","volume":"130","author":"Iba M","year":"2015","unstructured":"Iba, M., et al., Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections. Acta Neuropathol, 2015. 130(3): p.\u00a0349\u201362.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"e21050","DOI":"10.1371\/journal.pone.0021050","article-title":"P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating","volume":"6","author":"Takeuchi H","year":"2011","unstructured":"Takeuchi, H., et al., P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating. PLoS One, 2011. 6(6): p.\u00a0e21050.","journal-title":"PLoS One"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.toxlet.2012.12.023","article-title":"Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo","volume":"217","author":"Huang YJ","year":"2013","unstructured":"Huang, Y.J., et al., Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo. Toxicol Lett, 2013. 217(3): p.\u00a0184\u201391.","journal-title":"Toxicol Lett"},{"key":"ref28","author":"Kraeuter AK","year":"2019","unstructured":"Kraeuter, A.K., P.C. Guest, and Z. Sarnyai, The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice. Methods Mol Biol, 2019. 1916: p.\u00a0105\u2013111."},{"issue":"1","key":"ref29","first-page":"198","article-title":"Effects of chronic intranasal dantrolene on nasal mucosa morphology in mice","volume":"26","author":"Jiang B","year":"2022","unstructured":"Jiang, B., et al., Effects of chronic intranasal dantrolene on nasal mucosa morphology in mice. Eur Rev Med Pharmacol Sci, 2022. 26(1): p.\u00a0198\u2013203.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0773.1989.tb00621.x","article-title":"Van der Kleijn, Whole-body autoradiography of 14C-dantrolene in the marmoset monkey","volume":"64","author":"Wuis EW","year":"1989","unstructured":"Wuis, E.W., N.V. Rijntjes, and E. Van der Kleijn, Whole-body autoradiography of 14C-dantrolene in the marmoset monkey. Pharmacol Toxicol, 1989. 64(1): p.\u00a0156\u20138.","journal-title":"Pharmacol Toxicol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/WAD.0000000000000075","article-title":"Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice","volume":"29","author":"Wu Z","year":"2015","unstructured":"Wu, Z., et al., Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice. Alzheimer Dis Assoc Disord, 2015. 29(3): p.\u00a0184\u2013191.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"40","key":"ref32","doi-asserted-by":"crossref","first-page":"14436","DOI":"10.1523\/JNEUROSCI.3836-11.2011","article-title":"Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy","volume":"31","author":"Carroll JC","year":"2011","unstructured":"Carroll, J.C., et al., Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. J Neurosci, 2011. 31(40): p.\u00a014436\u201349.","journal-title":"J Neurosci"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40478-016-0378-4","article-title":"Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy","volume":"4","author":"Makani V","year":"2016","unstructured":"Makani, V., et al., Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy. Acta Neuropathol Commun, 2016. 4(1): p.\u00a0106.","journal-title":"Acta Neuropathol Commun"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2802620\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2802620\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T16:00:41Z","timestamp":1710864041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2802620\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":33,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2802620\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.3233\/JAD-231337","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,5,11]]},"subtype":"preprint"}}